Comments of DPR's RCD for Hydramethylnon
Comments of DPR's RCD for Hydramethylnon
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for the Active Ingredient Tetrahydro-5,5-dimethyl-2 (1H)-pyrimidinone {3[4-(trifluoromethyl) phenyl]-1-[2-(4-trifluoromethyl) phenyl] ethenyl]-2-propenylidene} hydrazone (hydramethylnon). These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in the attachment.
- Hydramethylnon